AICL/CLEC-2B Antibody (1A2)
Novus Biologicals, part of Bio-Techne | Catalog # H00009976-M02
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # 1A2
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CLEC2B (AAH05254, 1 a.a. ~ 149 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. MMTKHKKCFIIVGVLITTNIITLIVKLTRDSQSLCPYDWIGFQNKCYYFSKEEGDWNSSKYNCSTQHADLTIIDNIEETNFLRRYKCSSDHWIGLKMAKNRTGQWVDGATFTKSFGMRGSEGCAYLSDDGAATARCYTERKWICKKRIH
Specificity
Reacts with C-type lectin domain family 2, member B.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for AICL/CLEC-2B Antibody (1A2)
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
This antibody is reactive against recombinant protein in ELISA.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
In 1x PBS, pH 7.4
Preservative
No Preservative
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Background: AICL/CLEC-2B
Long Name
Activation-Induced C-Type Lectin
Alternate Names
CLEC-2B, CLEC2B, CLECSF2, IFNRG1
Entrez Gene IDs
9976 (Human)
Gene Symbol
CLEC2B
UniProt
Additional AICL/CLEC-2B Products
Product Documents for AICL/CLEC-2B Antibody (1A2)
Product Specific Notices for AICL/CLEC-2B Antibody (1A2)
This product is produced by and distributed for Abnova, a company based in Taiwan.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...